T C Fardon
Overview
Explore the profile of T C Fardon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDonnell M, Aliberti S, Goeminne P, Dimakou K, Zucchetti S, Davidson J, et al.
Thorax
. 2016 Aug;
71(12):1110-1118.
PMID: 27516225
Introduction: Bronchiectasis is a multidimensional disease associated with substantial morbidity and mortality. Two disease-specific clinical prediction tools have been developed, the Bronchiectasis Severity Index (BSI) and the FACED score, both...
2.
Clearie K, Jackson C, Fardon T, Williamson P, Vaidyanathan S, Burns P, et al.
Respir Med
. 2010 Dec;
105(4):558-65.
PMID: 21144723
Introduction: Current asthma guidelines recommend step-down of inhaled corticosteroids (ICS) to the minimum dose required for control of symptoms. Aim: To determine if supervised step-down of (ICS) in the community...
3.
Barnes M, Menzies D, Fardon T, Burns P, Wilson A, Lipworth B
Allergy
. 2006 Dec;
62(1):73-80.
PMID: 17156345
Background: Asthma and allergic rhinitis are manifestations of a single unified allergic airway, for which the best treatment is uncertain. Objective: To compare the anti-inflammatory efficacy in the unified allergic...
4.
Barnes M, Biallosterski B, Fujihara S, Gray R, Fardon T, Lipworth B
Allergy
. 2006 Sep;
61(11):1319-25.
PMID: 17002709
Background: Response to a single dose nasal adenosine monophosphate challenge has been used as a surrogate inflammatory marker for allergic rhinitis. Attenuation of response following intranasal corticosteroid would further validate...
5.
Barnes M, Ward J, Fardon T, Lipworth B
Clin Exp Allergy
. 2006 May;
36(5):676-84.
PMID: 16650054
Background: Addition of H(1) antagonists to intranasal corticosteroid treatment of allergic rhinitis (AR) is common in clinical practice and recommended by guidelines, despite some evidence that the additive benefits are...